Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,861 public trials 3,480 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT04447911

Conditions
Brain Diseases, Central Nervous System Diseases, Digestive System Diseases, +21 more
Locations
  • University Hospital of Würzburg, med. Poliklinik Würzburg, Germany
  • Erasmus Universität Medisch Centrum Rotterdam, Department of Internal Medicine Rotterdam, Netherlands
  • Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland
  • University Hospital Basel Basel, Switzerland
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 31 locations
View Trial Details
Recruiting

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

NCT07188896

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Carcinoma, +16 more
Locations
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

NCT06644755

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liposarcoma, +17 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • UZ Leuven Europe Leuven Leuven, Belgium
View Trial Details
Recruiting

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

NCT07463963

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Centre Hospitalier Universitaire d'Angers Angers, France
  • Centre Hospitalier Universitaire de Grenoble Alpes Grenoble, France
  • Centre Hospitalier de Chartres - Hôpital Louis Pasteur Le Coudray, France
  • Centre Hospitalier Universitaire de Lille Lille, France
View all 15 locations
View Trial Details

Related conditions